QT
CBAY

Quantbot Technologies’s Cymabay Therapeutics CBAY Stock Holding History

Quantbot Technologies’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,729
Closed -$5K – 2249
2022
Q1 		$5K Hold
1,729
– – ﹤0.01% 1541
2021
Q4 		$5K Sell
1,729
-200
-10% -$759 ﹤0.01% 1384
2021
Q3 		$7K Buy
+1,929
New +$7.6K ﹤0.01% 1388
2021
Q2 		– Sell
-22,915
Closed -$104K – 1970
2021
Q1 		$104K Sell
22,915
-1,550
-6% -$8.34K 0.01% 871
2020
Q4 		$140K Buy
+24,465
New +$185K 0.01% 682
2020
Q1 		– Sell
-3,917
Closed -$7K – 1506
2019
Q4 		$7K Sell
3,917
-2,783
-42% -$10.5K ﹤0.01% 1127
2019
Q3 		$34K Buy
6,700
+4,053
+153% +$24.5K ﹤0.01% 1053
2019
Q2 		$18K Buy
+2,647
New +$30K ﹤0.01% 1052
2018
Q2 		– Sell
-11,996
Closed -$155K – 1563
2018
Q1 		$155K Buy
+11,996
New +$149K 0.01% 745

Other funds holding CBAY

ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Quantbot Technologies's CBAY Position: Q2 2022 in Review

Quantbot Technologies sold out of Cymabay Therapeutics (CBAY) in Q2 2022, closing a stake of 1,729 shares — an estimated $5K sold.

Quantbot Technologies first reported a position in CBAY in Q1 2018 and held it in 9 quarters. The position peaked at $155K in Q1 2018. 106 funds tracked by Wall St. Rank hold CBAY as of Q2 2022.

  • Quantbot Technologies reported no remaining Cymabay Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Quantbot Technologies sold 1,729 Cymabay Therapeutics shares in Q2 2022, an estimated $5K.
  • Quantbot Technologies first reported a position in Cymabay Therapeutics in Q1 2018 and held it in 9 quarters.
  • Quantbot Technologies's Cymabay Therapeutics position peaked at $155K in Q1 2018.
  • 106 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.